共 204 条
[1]
Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[2]
Ferlay J(2018)Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 29 iv238-iv255
[3]
Siegel RL(2018)Hepatocellular carcinoma Lancet 391 1301-1314
[4]
Laversanne M(2018)Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial Lancet 391 1163-1173
[5]
Soerjomataram I(2008)Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378-390
[6]
Jemal A(2021)The current landscape of immune checkpoint blockade in hepatocellular carcinoma: a review JAMA Oncol 7 113-123
[7]
Bray F(2020)Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma N Engl J Med 382 1894-1905
[8]
Vogel A(2020)Phase Ib study of Lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma J Clin Oncol 38 2960-2970
[9]
Cervantes A(2018)Hepatocellular carcinoma with portal vein tumor involvement: best management strategies Semin Liver Dis 38 242-251
[10]
Chau I(2006)Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus World J Gastroenterol 12 7561-7567